Back

Predictors of Levosimendan reinitiation in patients with advanced heart failure undergoing intermittent inotropic therapy- is the lung that important?

20 March 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Pharmacotherapy ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Rodrigo Brandao

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

71 More presentations in this session

Presentation thumbnail
Multimodality imaging of the aortic root and ascending aorta: a comparative study of CTA and echocardiography
Mr G. Imperatore (Pisa, IT)
Abstract Slides
Presentation thumbnail
Impact of atrial fibrillation burden on heart failure device alerts and therapy delivery: insights from remote monitoring in an island-based heart failure cohor
Doctor I. Almeida (Ponta Delgada, PT)
Abstract Slides
Presentation thumbnail
Respiratory infections as triggers of acute cardiovascular complications: a case series of new-onset atrial fibrillation and heart failure
Doctor A. Akhtar (Waterford, IE)
Abstract Slides
Presentation thumbnail
Stabilizing the unstable: characterization of advanced heart failure patients under intermittent levosimendan therapy
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Four pillars of HFrEF: pilot study with real-world data
Doctor P. Radic (Zagreb, HR)
Abstract

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March - 21 March 2026
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Presentation
Early hospital management
thumbnail
Congress Presentation
Acute and advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources